- Home
- ZURA vs LCNB Comparison
ZURA vs LCNB Comparison
Compare ZURA & LCNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZURA | LCNB |
|---|---|---|
| Founded | 2022 | 1877 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 205.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ZURA | LCNB |
|---|---|---|
| Price | $4.31 | $17.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $11.38 | N/A |
| AVG Volume (30 Days) | ★ 369.0K | 29.2K |
| Earning Date | 11-13-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 5.23% |
| EPS Growth | N/A | ★ 220.73 |
| EPS | N/A | ★ 1.67 |
| Revenue | N/A | ★ $89,312,000.00 |
| Revenue This Year | N/A | $18.04 |
| Revenue Next Year | N/A | $4.36 |
| P/E Ratio | ★ N/A | $10.09 |
| Revenue Growth | N/A | ★ 19.58 |
| 52 Week Low | $0.97 | $13.34 |
| 52 Week High | $4.68 | $17.84 |
Technical Indicators
Market Signals| Indicator | ZURA | LCNB |
|---|---|---|
| Relative Strength Index (RSI) | 65.25 | 57.59 |
| Support Level | $3.88 | $16.82 |
| Resistance Level | $4.45 | $17.59 |
| Average True Range (ATR) | 0.25 | 0.41 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 89.36 | 58.95 |
Price Performance
Historical ComparisonAbout ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.